4.7 Article

Ubiquitin-proteasome pathway as a primary defender against TRAIL-mediated cell death

Journal

CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 61, Issue 9, Pages 1075-1081

Publisher

SPRINGER BASEL AG
DOI: 10.1007/s00018-004-3477-5

Keywords

proteasome; caspase; apoptosis; TRAIL; astrocytoma; ubiquitin

Funding

  1. NIMH NIH HHS [MH 64650] Funding Source: Medline
  2. NINDS NIH HHS [NS 36765, NS 29719] Funding Source: Medline

Ask authors/readers for more resources

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptotic cell death as well as expression of proinflammatory genes such as CXCL8 in malignant human astrocytoma cells. However, the molecular mechanisms that determine the fate of cells are not yet understood. The ubiquitin (Ub)-proteasome pathway regulates a wide range of cellular functions through degradation of various regulatory proteins; given this, we hypothesized that this pathway may play a central role in TRAIL-mediated signaling. We demonstrate here that inhibition of the Ub-proteasome pathway enhanced TRAIL-mediated cell death of human astrocytoma CRT-MG cells within hours by blocking degradation of active caspase-8 and -3. Proteasome inhibitors suppressed TRAIL-mediated activation of NF-kappaB; however, inhibition of the NF-kappaB pathway alone was not sufficient to enhance TRAIL-mediated cell death. Collectively, these results suggest that the Ub-proteasome pathway may play an important role as an antiapoptotic surveillance system by eliminating activated caspases as well as mediating NF-kappaB-dependent signals.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available